Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionTrexquant Investment LP
Latest Disclosed Ownership528,704 shares
Latest Disclosed Value $ 4,298,364
Trexquant Investment LP reports 132.52% increase in ownership of KUR / Kura Oncology, Inc.

On May 15, 2026 - Trexquant Investment LP filed a 13F-HR form disclosing ownership of 528,704 shares of Kura Oncology, Inc. (DE:KUR) valued at $3,515,882 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 227,382 shares of Kura Oncology, Inc.. This represents a change in shares of 132.52% during the quarter. The current value of the position is $3,997,002 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KURA ONCOLOGY COM 50127T109 528,704 301,322 132.52 4,298 81.96 0.0309
2026-02-17 2025-12-31 13F KURA ONCOLOGY COM 50127T109 227,382 12,339 5.74 2,362 24.12 0.0211
2025-11-14 2025-09-30 13F KURA ONCOLOGY COM 50127T109 215,043 -334,718 -60.88 1,903 -40.01 0.0196
2025-08-12 2025-06-30 13F KURA ONCOLOGY COM 50127T109 549,761 -136,209 -19.86 3,172 -29.93 0.0358
2025-05-14 2025-03-31 13F KURA ONCOLOGY COM 50127T109 685,970 119,025 20.99 4,527 -8.32 0.0527
2025-02-12 2024-12-31 13F KURA ONCOLOGY COM 50127T109 566,945 508,362 867.76 4,938 331.64 0.0576
2024-11-12 2024-09-30 13F KURA ONCOLOGY COM 50127T109 58,583 4,519 8.36 1,145 2.79 0.0145
2024-08-13 2024-06-30 13F KURA ONCOLOGY COM 50127T109 54,064 35,358 189.02 1,113 179.65 0.0170
2024-05-14 2024-03-31 13F KURA ONCOLOGY COM 50127T109 18,706 -45,321 -70.78 399 -56.74 0.0080
2024-02-09 2023-12-31 13F KURA ONCOLOGY COM 50127T109 64,027 27,312 74.39 921 175.45 0.0207
2023-11-13 2023-09-30 13F KURA ONCOLOGY COM 50127T109 36,715 -46,608 -55.94 335 -62.09 0.0084
2023-08-11 2023-06-30 13F KURA ONCOLOGY COM 50127T109 83,323 83,323 882 0.0231
2023-02-13 2022-12-31 13F KURA ONCOLOGY COM 50127T109 0 -53,641 -100.00 0 -100.00
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 53,641 33,866 171.26 733 102.49 0.0258
2022-08-11 2022-06-30 13F KURA ONCOLOGY COM 50127T109 19,775 19,775 362 0.0162
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 0 -13,768 -100.00 0 -100.00
2022-02-14 2021-12-31 13F KURA ONCOLOGY COM 50127T109 13,768 1,008 7.90 193 -19.25 0.0119
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM 50127T109 12,760 -11,296 -46.96 239 -52.39 0.0190
2021-08-12 2021-06-30 13F KURA ONCOLOGY COM 50127T109 24,056 16,296 210.00 502 129.22 0.0424
2021-05-13 2021-03-31 13F KURA ONCOLOGY COM 50127T109 7,760 -14,615 -65.32 219 -70.04 0.0201
2021-02-11 2020-12-31 13F KURA ONCOLOGY COM 50127T109 22,375 22,375 731 0.0774
2020-11-06 2020-09-30 13F KURA ONCOLOGY COM 50127T109 0 -17,001 -100.00 0 -100.00
2020-08-07 2020-06-30 13F KURA ONCOLOGY COM 50127T109 17,001 -14,085 -45.31 277 -10.36 0.0192
2020-05-08 2020-03-31 13F KURA ONCOLOGY COM 50127T109 31,086 18,825 153.54 309 82.84 0.0224
2020-02-12 2019-12-31 13F KURA ONCOLOGY COM 50127T109 12,261 12,261 169 0.0100
2019-02-13 2018-12-31 13F KURA ONCOLOGY COM 50127T109 0 -12,396 -100.00 0 -100.00
2018-11-09 2018-09-30 13F KURA ONCOLOGY COM 50127T109 12,396 12,396 217 0.0163
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.